New Perspective of GABA as an Inhibitor of Formation of Advanced Lipoxidation End-Products: It's Interaction with Malondiadehyde

被引:96
作者
Deng, Yan [1 ,2 ]
Xu, Lijian [2 ]
Zeng, Xin [1 ]
Li, Zhiyang [1 ]
Qin, Binbing [1 ]
He, Nongyue [1 ,2 ]
机构
[1] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Peoples R China
[2] Hunan Univ Technol, Hunan Key Lab Green Packaging & Applicat Biol Nan, Zhuzhou 412008, Peoples R China
基金
湖南省自然科学基金; 中国国家自然科学基金;
关键词
Lipid Peroxidation; Reactive Carbonyl Compounds; Malondialdehyde (MDA); Gamma-Aminobutyric Acid (GABA); Scavenging; GAMMA-AMINOBUTYRIC ACID; OXIDATIVE STRESS; DRUG-DELIVERY; LIPID-PEROXIDATION; IN-VIVO; PHOSPHATE NANOPARTICLES; PEROXIDIZED LIPIDS; GENE DELIVERY; MALONDIALDEHYDE; ADDUCTS;
D O I
10.1166/jbn.2010.1130
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
In this research, the obtained evidences support the hypothesis that gamma-aminobutyric acid (r-aminobutyric acid, GABA) can trap malondialdehyde (MDA) indirectly or directly. In vitro, reaction between GABA with fatty acid, which can be confirmed by detecting the formation and yield of MDA and the consumption of GABA, shows that GABA can trap the reactive intermediates during lipid peroxidation. Further study of the direct reaction between GABA and MDA indicated that GABA reacts readily with MDA under supraphysiological conditions to form different products. A nonfluorescent enamine (product 1) and a lipofuscin-like fluorescent 1,4-dihydropyridine (product 2) were obtained experimentally from reaction of equimolar of GABA+MDA and were detected by means of high performance liquid chromatography (HPLC) separation for the reaction mixtures at 48 h. We proposed a mechanism for the formation of these products from oxidation of polyunsaturated fatty acids (PUFA) to the reaction of GABA and MDA. The results suggest that the scavenging effects of GABA on reactive carbonyl compounds may play an important role in inhibiting the formation of advanced lipoxidation end-products (ALEs), and GABA, as a potent antioxidant or additive, is a novel functional factor for nutraceuticals.
引用
收藏
页码:318 / 324
页数:7
相关论文
共 56 条
  • [1] Ahmad R, 2008, IN VIVO, V22, P525
  • [2] The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins:: a mechanism for producing advances glycation end products at sites of inflammation
    Anderson, MM
    Requena, JR
    Crowley, JR
    Thorpe, SR
    Heinecke, JW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) : 103 - 113
  • [3] [Anonymous], 1989, FREE RADICAL BIO MED
  • [4] Role of oxidative stress in diabetic complications - A new perspective on an old paradigm
    Baynes, JW
    Thorpe, SR
    [J]. DIABETES, 1999, 48 (01) : 1 - 9
  • [5] Protein oxidation in aging, disease, and oxidative stress
    Berlett, BS
    Stadtman, ER
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) : 20313 - 20316
  • [6] Magnesium Phosphate Nanoparticles can be Efficiently Used In Vitro and In Vivo as Non-Viral Vectors for Targeted Gene Delivery
    Bhakta, Gajadhar
    Shrivastava, Anju
    Maitra, Amarnath
    [J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2009, 5 (01) : 106 - 114
  • [7] Lipid Nanoparticles for Drug Delivery to the Brain: In Vivo Veritas
    Blasi, Paolo
    Schoubben, Aurelie
    Giovagnoli, Stefano
    Rossi, Carlo
    Ricci, Maurizio
    [J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2009, 5 (04) : 344 - 350
  • [8] Browne SE, 1999, BRAIN PATHOL, V9, P147
  • [9] Ionically Crosslinked Chitosan Nanoparticles as Gene Delivery Systems: Effect of PEGylation Degree on In Vitro and In Vivo Gene Transfer
    Csaba, Noemi
    Koping-Hoggard, Magnus
    Fernandez-Megia, Eduardo
    Novoa-Carballal, Ramon
    Riguera, Ricardo
    Jose Alonso, Maria
    [J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2009, 5 (02) : 162 - 171
  • [10] Protein carbonylation in human diseases
    Dalle-Donne, I
    Giustarini, D
    Colombo, R
    Rossi, R
    Milzani, A
    [J]. TRENDS IN MOLECULAR MEDICINE, 2003, 9 (04) : 169 - 176